Wissenschaftlicher Artikel

Chronic Hepatitis E in rheumatology and internal medicine patients: A retrospective multicenter European cohort study

Personen-Informationen ausblenden
a Erst-Autor:in
b Autor:in mit gleichen Anteilen
c Letzt-Autor:in

Erschienen in
Viruses ,  11  (2019) , 2 , 186 . https://doi.org/10.3390/v11020186
ISSN: 1999-4915
Basel  :  MDPI AG

Bibliographische Angaben
Erscheinungsjahr: 2019
URN: urn:nbn:de:bsz:25-freidok-1493456 Sprache: englisch Technik / Medizin und Gesundheit
Abstract
  • englisch
Objectives: Hepatitis E virus (HEV) infection is a pandemic with regional outbreaks, including in industrialized countries. HEV infection is usually self-limiting but can progress to chronic hepatitis E in transplant recipients and HIV-infected patients. Whether other immunocompromised hosts, including rheumatology and internal medicine patients, are at risk of developing chronic HEV infection is unclear. Methods: We conducted a retrospective European multicenter cohort study involving 21 rheumatology and internal medicine patients with HEV infection between April 2014 and April 2016. The underlying diseases included rheumatoid arthritis (n = 5), psoriatic arthritis (n = 4), other variants of chronic arthritis (n = 4), primary immunodeficiency (n = 3), systemic granulomatosis (n = 2), lupus erythematosus (n = 1), Erdheim–Chester disease (n = 1), and retroperitoneal fibrosis (n = 1). Results: HEV infection lasting longer than 3 months was observed in seven (33%) patients, including two (40%) patients with rheumatoid arthritis, three (100%) patients with primary immunodeficiency, one (100%) patient with retroperitoneal fibrosis and one (100%) patient with systemic granulomatosis. Patients with HEV infection lasting longer than 3 months were treated with methotrexate without corticosteroids (n = 2), mycophenolate mofetil/prednisone (n = 1), and sirolimus/prednisone (n = 1). Overall, 8/21 (38%) and 11/21 (52%) patients cleared HEV with and without ribavirin treatment, respectively. One patient experienced an HEV relapse after initially successful ribavirin therapy. One patient (5%) was lost to follow-up, and no patients died from hepatic complications. Conclusion: Rheumatology and internal medicine patients, including patients treated with methotrexate without corticosteroids, are at risk of developing chronic HEV infection. Rheumatology and internal medicine patients with abnormal liver tests should be screened for HEV infection.

Beschreibung
  • Bemerkung
This article belongs to the special issue: Hepatitis E virus

Dateien
Lizenz Creative Commons CC BY (Namensnennung
)
DFG
Dieser Beitrag ist mit Zustimmung des Rechteinhabers (Verlag) aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich.
 
Chronic Hepatitis E in rheumatology and internal medicine patients: A retrospective multicenter European cohort study



ist lizenziert unter einer
  • viruses-11-00186.pdf SHA256 checksum: 923854de692848e8b73ae83f57786d132323f33177aaeddf232973825e46a106
    Download (393.23 KB)

  • Beschreibung der Forschungsdaten

    mehr weniger
    Relationen
    Laden...
    Laden...

    Korrekturanfrage
    Vielen Dank für Ihre Korrekturanfrage. Wir werden uns um Ihre Anfrage kümmern und uns ggf. über die angegebene E-Mail-Adresse bei Ihnen zurückmelden. Bitte haben Sie Verständnis dafür, dass die Korrektur unter Umständen einige Tage dauern kann.
    Es ist ein Fehler aufgetreten. Bitte versuchen Sie es später noch einmal.